Camp4 Therapeutics (CAMP) Cash from Operations (2023 - 2026)

Camp4 Therapeutics has reported Cash from Operations for 4 years, with the latest figure at 10981000.0 in Q1 2026.

• Quarterly Cash from Operations rose 23.13% year-over-year to 10981000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 26248000.0 (up 46.11% YoY) and the FY2025 annual result came in at 29553000.0, up 35.14% from the prior year.
• Cash from Operations fell to 10981000.0 in Q1 2026 per CAMP's latest filing, from 6247000.0 in the prior quarter.
• Over five years, Cash from Operations peaked at 6247000.0 in Q4 2025 and troughed at 14286000.0 in Q1 2025.
• A 4-year average of 9787900.0 and a median of 11157000.0 in 2024 frame the typical range for Cash from Operations.
• The widest YoY moves for Cash from Operations: up 155.34% in 2025, down 28.21% in 2025.
• Over 4 years, Cash from Operations stood at 11783000.0 in 2023, then advanced by 4.2% to 11288000.0 in 2024, then soared by 155.34% to 6247000.0 in 2025, then tumbled by 275.78% to 10981000.0 in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered 10981000.0, 6247000.0, and 11171000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.